nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1B1—Progesterone—uterine cancer	0.14	0.195	CbGbCtD
Propofol—CYP2A6—Progesterone—uterine cancer	0.0719	0.1	CbGbCtD
Propofol—CYP1A1—Progesterone—uterine cancer	0.0614	0.0855	CbGbCtD
Propofol—UGT1A1—Etoposide—uterine cancer	0.0541	0.0753	CbGbCtD
Propofol—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0535	0.0745	CbGbCtD
Propofol—CYP1B1—Doxorubicin—uterine cancer	0.0427	0.0595	CbGbCtD
Propofol—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0373	0.0519	CbGbCtD
Propofol—CYP2C8—Progesterone—uterine cancer	0.0355	0.0493	CbGbCtD
Propofol—CYP2C19—Progesterone—uterine cancer	0.0297	0.0414	CbGbCtD
Propofol—CYP1A2—Progesterone—uterine cancer	0.0274	0.0382	CbGbCtD
Propofol—CYP2C9—Progesterone—uterine cancer	0.0247	0.0344	CbGbCtD
Propofol—CYP2D6—Progesterone—uterine cancer	0.0226	0.0315	CbGbCtD
Propofol—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0217	0.0302	CbGbCtD
Propofol—CYP2E1—Etoposide—uterine cancer	0.0212	0.0295	CbGbCtD
Propofol—CYP2C8—Etoposide—uterine cancer	0.0159	0.0221	CbGbCtD
Propofol—CYP3A4—Progesterone—uterine cancer	0.0144	0.02	CbGbCtD
Propofol—CYP2B6—Doxorubicin—uterine cancer	0.0143	0.0199	CbGbCtD
Propofol—CYP1A2—Etoposide—uterine cancer	0.0123	0.0171	CbGbCtD
Propofol—CYP2D6—Doxorubicin—uterine cancer	0.0069	0.0096	CbGbCtD
Propofol—CYP3A4—Etoposide—uterine cancer	0.00643	0.00895	CbGbCtD
Propofol—CYP3A4—Doxorubicin—uterine cancer	0.00439	0.00611	CbGbCtD
Propofol—UGT1A8—renal system—uterine cancer	0.00261	0.063	CbGeAlD
Propofol—FAAH—decidua—uterine cancer	0.00193	0.0467	CbGeAlD
Propofol—FAAH—renal system—uterine cancer	0.0019	0.0458	CbGeAlD
Propofol—FAAH—endometrium—uterine cancer	0.00184	0.0443	CbGeAlD
Propofol—FAAH—mammalian vulva—uterine cancer	0.00178	0.0428	CbGeAlD
Propofol—UGT1A9—renal system—uterine cancer	0.00166	0.04	CbGeAlD
Propofol—CYP2C18—uterine cervix—uterine cancer	0.00155	0.0374	CbGeAlD
Propofol—FAAH—female reproductive system—uterine cancer	0.00152	0.0367	CbGeAlD
Propofol—FAAH—female gonad—uterine cancer	0.00138	0.0334	CbGeAlD
Propofol—FAAH—vagina—uterine cancer	0.00137	0.0332	CbGeAlD
Propofol—CYP2C18—mammalian vulva—uterine cancer	0.00136	0.0327	CbGeAlD
Propofol—SCN4A—renal system—uterine cancer	0.00123	0.0298	CbGeAlD
Propofol—UGT1A1—renal system—uterine cancer	0.00114	0.0274	CbGeAlD
Propofol—CYP2C18—vagina—uterine cancer	0.00105	0.0253	CbGeAlD
Propofol—FAAH—lymph node—uterine cancer	0.000889	0.0215	CbGeAlD
Propofol—SCN2A—vagina—uterine cancer	0.00079	0.0191	CbGeAlD
Propofol—CYP1B1—smooth muscle tissue—uterine cancer	0.00073	0.0176	CbGeAlD
Propofol—CYP1B1—decidua—uterine cancer	0.000715	0.0173	CbGeAlD
Propofol—CYP1B1—renal system—uterine cancer	0.000703	0.017	CbGeAlD
Propofol—CYP2A6—vagina—uterine cancer	0.000694	0.0168	CbGeAlD
Propofol—CYP1B1—uterus—uterine cancer	0.000626	0.0151	CbGeAlD
Propofol—GABRA2—vagina—uterine cancer	0.000613	0.0148	CbGeAlD
Propofol—GABRB3—female reproductive system—uterine cancer	0.00057	0.0138	CbGeAlD
Propofol—CYP1B1—female reproductive system—uterine cancer	0.000563	0.0136	CbGeAlD
Propofol—CYP2C8—renal system—uterine cancer	0.000538	0.013	CbGeAlD
Propofol—CYP1A1—epithelium—uterine cancer	0.000535	0.0129	CbGeAlD
Propofol—CYP1A1—uterine cervix—uterine cancer	0.000531	0.0128	CbGeAlD
Propofol—CYP2C8—endometrium—uterine cancer	0.00052	0.0126	CbGeAlD
Propofol—CYP1B1—female gonad—uterine cancer	0.000512	0.0124	CbGeAlD
Propofol—CYP1A2—renal system—uterine cancer	0.000503	0.0122	CbGeAlD
Propofol—CYP1A1—renal system—uterine cancer	0.000497	0.012	CbGeAlD
Propofol—CYP2B6—renal system—uterine cancer	0.000483	0.0116	CbGeAlD
Propofol—CYP1A1—mammalian vulva—uterine cancer	0.000464	0.0112	CbGeAlD
Propofol—CYP2E1—renal system—uterine cancer	0.000453	0.0109	CbGeAlD
Propofol—CYP2C19—vagina—uterine cancer	0.000446	0.0108	CbGeAlD
Propofol—CYP1A1—uterus—uterine cancer	0.000442	0.0107	CbGeAlD
Propofol—CYP2C8—female reproductive system—uterine cancer	0.000431	0.0104	CbGeAlD
Propofol—CYP1A1—female reproductive system—uterine cancer	0.000398	0.0096	CbGeAlD
Propofol—GABRA2—lymph node—uterine cancer	0.000397	0.00958	CbGeAlD
Propofol—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00039	0.00239	CcSEcCtD
Propofol—CYP2C8—vagina—uterine cancer	0.00039	0.0094	CbGeAlD
Propofol—Oliguria—Epirubicin—uterine cancer	0.000389	0.00238	CcSEcCtD
Propofol—CYP2B6—female reproductive system—uterine cancer	0.000387	0.00933	CbGeAlD
Propofol—Erythema—Dactinomycin—uterine cancer	0.000386	0.00236	CcSEcCtD
Propofol—Delirium—Doxorubicin—uterine cancer	0.000385	0.00236	CcSEcCtD
Propofol—Fatigue—Progesterone—uterine cancer	0.000384	0.00235	CcSEcCtD
Propofol—CYP2C9—female reproductive system—uterine cancer	0.000383	0.00924	CbGeAlD
Propofol—Dyskinesia—Epirubicin—uterine cancer	0.000381	0.00233	CcSEcCtD
Propofol—Pain—Progesterone—uterine cancer	0.000381	0.00233	CcSEcCtD
Propofol—Extravasation—Doxorubicin—uterine cancer	0.00038	0.00233	CcSEcCtD
Propofol—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000377	0.00231	CcSEcCtD
Propofol—Creatinine increased—Epirubicin—uterine cancer	0.000376	0.0023	CcSEcCtD
Propofol—Atrioventricular block—Epirubicin—uterine cancer	0.000369	0.00226	CcSEcCtD
Propofol—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000368	0.00225	CcSEcCtD
Propofol—Feeling abnormal—Progesterone—uterine cancer	0.000367	0.00225	CcSEcCtD
Propofol—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.000367	0.00225	CcSEcCtD
Propofol—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000365	0.00224	CcSEcCtD
Propofol—CYP3A4—renal system—uterine cancer	0.000364	0.00879	CbGeAlD
Propofol—CYP2E1—female reproductive system—uterine cancer	0.000363	0.00875	CbGeAlD
Propofol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000363	0.00222	CcSEcCtD
Propofol—Thinking abnormal—Doxorubicin—uterine cancer	0.000362	0.00222	CcSEcCtD
Propofol—CYP1A1—female gonad—uterine cancer	0.000362	0.00873	CbGeAlD
Propofol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00036	0.0022	CcSEcCtD
Propofol—CYP1A1—vagina—uterine cancer	0.00036	0.00868	CbGeAlD
Propofol—Oliguria—Doxorubicin—uterine cancer	0.00036	0.0022	CcSEcCtD
Propofol—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000359	0.0022	CcSEcCtD
Propofol—ALB—lymph node—uterine cancer	0.000359	0.00866	CbGeAlD
Propofol—CYP2D6—renal system—uterine cancer	0.000359	0.00865	CbGeAlD
Propofol—Hiccups—Epirubicin—uterine cancer	0.000358	0.00219	CcSEcCtD
Propofol—Ventricular tachycardia—Epirubicin—uterine cancer	0.000358	0.00219	CcSEcCtD
Propofol—Urticaria—Progesterone—uterine cancer	0.000354	0.00217	CcSEcCtD
Propofol—Abnormal dreams—Epirubicin—uterine cancer	0.000354	0.00217	CcSEcCtD
Propofol—Dyskinesia—Doxorubicin—uterine cancer	0.000353	0.00216	CcSEcCtD
Propofol—Acute coronary syndrome—Etoposide—uterine cancer	0.000352	0.00216	CcSEcCtD
Propofol—Body temperature increased—Progesterone—uterine cancer	0.000352	0.00216	CcSEcCtD
Propofol—Abdominal pain—Progesterone—uterine cancer	0.000352	0.00216	CcSEcCtD
Propofol—Hyperkalaemia—Epirubicin—uterine cancer	0.000352	0.00215	CcSEcCtD
Propofol—Renal failure—Etoposide—uterine cancer	0.000351	0.00215	CcSEcCtD
Propofol—Myocardial infarction—Etoposide—uterine cancer	0.00035	0.00215	CcSEcCtD
Propofol—Neuropathy peripheral—Etoposide—uterine cancer	0.00035	0.00215	CcSEcCtD
Propofol—CYP2B6—vagina—uterine cancer	0.00035	0.00844	CbGeAlD
Propofol—Creatinine increased—Doxorubicin—uterine cancer	0.000348	0.00213	CcSEcCtD
Propofol—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000348	0.00213	CcSEcCtD
Propofol—Salivary hypersecretion—Epirubicin—uterine cancer	0.000348	0.00213	CcSEcCtD
Propofol—Atrioventricular block—Doxorubicin—uterine cancer	0.000342	0.00209	CcSEcCtD
Propofol—Blood urea increased—Epirubicin—uterine cancer	0.000338	0.00207	CcSEcCtD
Propofol—Neuropathy—Epirubicin—uterine cancer	0.000336	0.00206	CcSEcCtD
Propofol—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000333	0.00204	CcSEcCtD
Propofol—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000331	0.00203	CcSEcCtD
Propofol—Hiccups—Doxorubicin—uterine cancer	0.000331	0.00203	CcSEcCtD
Propofol—CYP1B1—lymph node—uterine cancer	0.000329	0.00794	CbGeAlD
Propofol—Myalgia—Dactinomycin—uterine cancer	0.000329	0.00201	CcSEcCtD
Propofol—Abnormal dreams—Doxorubicin—uterine cancer	0.000328	0.00201	CcSEcCtD
Propofol—Hyperkalaemia—Doxorubicin—uterine cancer	0.000326	0.00199	CcSEcCtD
Propofol—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000322	0.00197	CcSEcCtD
Propofol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000321	0.00196	CcSEcCtD
Propofol—Asthenia—Progesterone—uterine cancer	0.00032	0.00196	CcSEcCtD
Propofol—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000319	0.00195	CcSEcCtD
Propofol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000319	0.00195	CcSEcCtD
Propofol—Pulmonary oedema—Epirubicin—uterine cancer	0.000319	0.00195	CcSEcCtD
Propofol—Pruritus—Progesterone—uterine cancer	0.000315	0.00193	CcSEcCtD
Propofol—Oedema—Dactinomycin—uterine cancer	0.000315	0.00193	CcSEcCtD
Propofol—Hypertonia—Epirubicin—uterine cancer	0.000314	0.00192	CcSEcCtD
Propofol—Blood urea increased—Doxorubicin—uterine cancer	0.000313	0.00192	CcSEcCtD
Propofol—Abnormal vision—Epirubicin—uterine cancer	0.000312	0.00191	CcSEcCtD
Propofol—Neuropathy—Doxorubicin—uterine cancer	0.000311	0.00191	CcSEcCtD
Propofol—Sepsis—Epirubicin—uterine cancer	0.000311	0.0019	CcSEcCtD
Propofol—Mental disability—Epirubicin—uterine cancer	0.000311	0.0019	CcSEcCtD
Propofol—Diarrhoea—Progesterone—uterine cancer	0.000305	0.00187	CcSEcCtD
Propofol—Phlebitis—Epirubicin—uterine cancer	0.000302	0.00185	CcSEcCtD
Propofol—Flushing—Etoposide—uterine cancer	0.000298	0.00182	CcSEcCtD
Propofol—Pulmonary oedema—Doxorubicin—uterine cancer	0.000295	0.00181	CcSEcCtD
Propofol—Dizziness—Progesterone—uterine cancer	0.000295	0.0018	CcSEcCtD
Propofol—CYP3A4—female reproductive system—uterine cancer	0.000292	0.00704	CbGeAlD
Propofol—Hypertonia—Doxorubicin—uterine cancer	0.000291	0.00178	CcSEcCtD
Propofol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00029	0.00177	CcSEcCtD
Propofol—Abnormal vision—Doxorubicin—uterine cancer	0.000289	0.00177	CcSEcCtD
Propofol—Eye pain—Epirubicin—uterine cancer	0.000288	0.00176	CcSEcCtD
Propofol—Chills—Etoposide—uterine cancer	0.000288	0.00176	CcSEcCtD
Propofol—Mental disability—Doxorubicin—uterine cancer	0.000288	0.00176	CcSEcCtD
Propofol—Sepsis—Doxorubicin—uterine cancer	0.000288	0.00176	CcSEcCtD
Propofol—CYP2D6—female reproductive system—uterine cancer	0.000287	0.00693	CbGeAlD
Propofol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000287	0.00176	CcSEcCtD
Propofol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.00175	CcSEcCtD
Propofol—Vomiting—Progesterone—uterine cancer	0.000283	0.00173	CcSEcCtD
Propofol—Rash—Progesterone—uterine cancer	0.000281	0.00172	CcSEcCtD
Propofol—Dermatitis—Progesterone—uterine cancer	0.000281	0.00172	CcSEcCtD
Propofol—Phlebitis—Doxorubicin—uterine cancer	0.000279	0.00171	CcSEcCtD
Propofol—Headache—Progesterone—uterine cancer	0.000279	0.00171	CcSEcCtD
Propofol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.00169	CcSEcCtD
Propofol—Dysgeusia—Etoposide—uterine cancer	0.000274	0.00167	CcSEcCtD
Propofol—Fatigue—Dactinomycin—uterine cancer	0.000272	0.00166	CcSEcCtD
Propofol—Pain—Dactinomycin—uterine cancer	0.000269	0.00165	CcSEcCtD
Propofol—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000269	0.00164	CcSEcCtD
Propofol—Muscle spasms—Etoposide—uterine cancer	0.000269	0.00164	CcSEcCtD
Propofol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000267	0.00163	CcSEcCtD
Propofol—Eye pain—Doxorubicin—uterine cancer	0.000267	0.00163	CcSEcCtD
Propofol—Cardiac failure—Epirubicin—uterine cancer	0.000266	0.00163	CcSEcCtD
Propofol—Nausea—Progesterone—uterine cancer	0.000265	0.00162	CcSEcCtD
Propofol—CYP2D6—female gonad—uterine cancer	0.000261	0.00631	CbGeAlD
Propofol—Pain in extremity—Epirubicin—uterine cancer	0.00026	0.00159	CcSEcCtD
Propofol—Diplopia—Epirubicin—uterine cancer	0.00026	0.00159	CcSEcCtD
Propofol—Feeling abnormal—Dactinomycin—uterine cancer	0.00026	0.00159	CcSEcCtD
Propofol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000257	0.00157	CcSEcCtD
Propofol—Affect lability—Epirubicin—uterine cancer	0.000256	0.00157	CcSEcCtD
Propofol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000255	0.00156	CcSEcCtD
Propofol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000254	0.00156	CcSEcCtD
Propofol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.00155	CcSEcCtD
Propofol—Abdominal pain—Dactinomycin—uterine cancer	0.000249	0.00152	CcSEcCtD
Propofol—Body temperature increased—Dactinomycin—uterine cancer	0.000249	0.00152	CcSEcCtD
Propofol—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000249	0.00152	CcSEcCtD
Propofol—Cardiac arrest—Epirubicin—uterine cancer	0.000247	0.00151	CcSEcCtD
Propofol—Cardiac failure—Doxorubicin—uterine cancer	0.000247	0.00151	CcSEcCtD
Propofol—Mood swings—Epirubicin—uterine cancer	0.000246	0.00151	CcSEcCtD
Propofol—Loss of consciousness—Etoposide—uterine cancer	0.000246	0.0015	CcSEcCtD
Propofol—Cough—Etoposide—uterine cancer	0.000244	0.00149	CcSEcCtD
Propofol—Blood creatinine increased—Epirubicin—uterine cancer	0.000244	0.00149	CcSEcCtD
Propofol—Convulsion—Etoposide—uterine cancer	0.000242	0.00148	CcSEcCtD
Propofol—Dehydration—Epirubicin—uterine cancer	0.000242	0.00148	CcSEcCtD
Propofol—Hypertension—Etoposide—uterine cancer	0.000241	0.00148	CcSEcCtD
Propofol—Pain in extremity—Doxorubicin—uterine cancer	0.000241	0.00147	CcSEcCtD
Propofol—Diplopia—Doxorubicin—uterine cancer	0.000241	0.00147	CcSEcCtD
Propofol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00147	CcSEcCtD
Propofol—Chest pain—Etoposide—uterine cancer	0.000238	0.00146	CcSEcCtD
Propofol—Affect lability—Doxorubicin—uterine cancer	0.000237	0.00145	CcSEcCtD
Propofol—CYP1A1—lymph node—uterine cancer	0.000233	0.00562	CbGeAlD
Propofol—Confusional state—Etoposide—uterine cancer	0.00023	0.00141	CcSEcCtD
Propofol—Cardiac arrest—Doxorubicin—uterine cancer	0.000229	0.0014	CcSEcCtD
Propofol—Anaphylactic shock—Etoposide—uterine cancer	0.000228	0.0014	CcSEcCtD
Propofol—Mood swings—Doxorubicin—uterine cancer	0.000228	0.0014	CcSEcCtD
Propofol—Asthenia—Dactinomycin—uterine cancer	0.000226	0.00138	CcSEcCtD
Propofol—Blood creatinine increased—Doxorubicin—uterine cancer	0.000225	0.00138	CcSEcCtD
Propofol—Dehydration—Doxorubicin—uterine cancer	0.000224	0.00137	CcSEcCtD
Propofol—Tachycardia—Etoposide—uterine cancer	0.000223	0.00136	CcSEcCtD
Propofol—Hyperhidrosis—Etoposide—uterine cancer	0.00022	0.00135	CcSEcCtD
Propofol—Pancreatitis—Epirubicin—uterine cancer	0.00022	0.00135	CcSEcCtD
Propofol—Diarrhoea—Dactinomycin—uterine cancer	0.000216	0.00132	CcSEcCtD
Propofol—Hypotension—Etoposide—uterine cancer	0.000213	0.0013	CcSEcCtD
Propofol—Paraesthesia—Etoposide—uterine cancer	0.000205	0.00125	CcSEcCtD
Propofol—Pancreatitis—Doxorubicin—uterine cancer	0.000204	0.00125	CcSEcCtD
Propofol—Dyspnoea—Etoposide—uterine cancer	0.000203	0.00124	CcSEcCtD
Propofol—Hyperglycaemia—Epirubicin—uterine cancer	0.000203	0.00124	CcSEcCtD
Propofol—Somnolence—Etoposide—uterine cancer	0.000203	0.00124	CcSEcCtD
Propofol—Vomiting—Dactinomycin—uterine cancer	0.0002	0.00123	CcSEcCtD
Propofol—Rash—Dactinomycin—uterine cancer	0.000199	0.00122	CcSEcCtD
Propofol—Renal failure—Epirubicin—uterine cancer	0.000197	0.00121	CcSEcCtD
Propofol—Fatigue—Etoposide—uterine cancer	0.000197	0.0012	CcSEcCtD
Propofol—Neuropathy peripheral—Epirubicin—uterine cancer	0.000196	0.0012	CcSEcCtD
Propofol—Pain—Etoposide—uterine cancer	0.000195	0.00119	CcSEcCtD
Propofol—Feeling abnormal—Etoposide—uterine cancer	0.000188	0.00115	CcSEcCtD
Propofol—Hyperglycaemia—Doxorubicin—uterine cancer	0.000188	0.00115	CcSEcCtD
Propofol—Nausea—Dactinomycin—uterine cancer	0.000187	0.00115	CcSEcCtD
Propofol—Bradycardia—Epirubicin—uterine cancer	0.000183	0.00112	CcSEcCtD
Propofol—Renal failure—Doxorubicin—uterine cancer	0.000182	0.00112	CcSEcCtD
Propofol—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000182	0.00111	CcSEcCtD
Propofol—Urticaria—Etoposide—uterine cancer	0.000181	0.00111	CcSEcCtD
Propofol—Haemoglobin—Epirubicin—uterine cancer	0.000181	0.00111	CcSEcCtD
Propofol—Abdominal pain—Etoposide—uterine cancer	0.00018	0.0011	CcSEcCtD
Propofol—Body temperature increased—Etoposide—uterine cancer	0.00018	0.0011	CcSEcCtD
Propofol—Haemorrhage—Epirubicin—uterine cancer	0.00018	0.0011	CcSEcCtD
Propofol—Pharyngitis—Epirubicin—uterine cancer	0.000179	0.00109	CcSEcCtD
Propofol—Visual impairment—Epirubicin—uterine cancer	0.000173	0.00106	CcSEcCtD
Propofol—Bradycardia—Doxorubicin—uterine cancer	0.000169	0.00104	CcSEcCtD
Propofol—Tinnitus—Epirubicin—uterine cancer	0.000168	0.00103	CcSEcCtD
Propofol—Haemoglobin—Doxorubicin—uterine cancer	0.000167	0.00102	CcSEcCtD
Propofol—Flushing—Epirubicin—uterine cancer	0.000167	0.00102	CcSEcCtD
Propofol—Haemorrhage—Doxorubicin—uterine cancer	0.000166	0.00102	CcSEcCtD
Propofol—Pharyngitis—Doxorubicin—uterine cancer	0.000165	0.00101	CcSEcCtD
Propofol—Asthenia—Etoposide—uterine cancer	0.000164	0.001	CcSEcCtD
Propofol—Chills—Epirubicin—uterine cancer	0.000161	0.000988	CcSEcCtD
Propofol—Pruritus—Etoposide—uterine cancer	0.000161	0.000987	CcSEcCtD
Propofol—Arrhythmia—Epirubicin—uterine cancer	0.000161	0.000984	CcSEcCtD
Propofol—Visual impairment—Doxorubicin—uterine cancer	0.00016	0.000982	CcSEcCtD
Propofol—Erythema—Epirubicin—uterine cancer	0.000157	0.000959	CcSEcCtD
Propofol—Diarrhoea—Etoposide—uterine cancer	0.000156	0.000955	CcSEcCtD
Propofol—Tinnitus—Doxorubicin—uterine cancer	0.000155	0.00095	CcSEcCtD
Propofol—Flushing—Doxorubicin—uterine cancer	0.000154	0.000946	CcSEcCtD
Propofol—Dysgeusia—Epirubicin—uterine cancer	0.000153	0.000939	CcSEcCtD
Propofol—Dizziness—Etoposide—uterine cancer	0.000151	0.000923	CcSEcCtD
Propofol—Muscle spasms—Epirubicin—uterine cancer	0.000151	0.000922	CcSEcCtD
Propofol—Chills—Doxorubicin—uterine cancer	0.000149	0.000914	CcSEcCtD
Propofol—Arrhythmia—Doxorubicin—uterine cancer	0.000149	0.00091	CcSEcCtD
Propofol—Vomiting—Etoposide—uterine cancer	0.000145	0.000887	CcSEcCtD
Propofol—Erythema—Doxorubicin—uterine cancer	0.000145	0.000887	CcSEcCtD
Propofol—Agitation—Epirubicin—uterine cancer	0.000144	0.000881	CcSEcCtD
Propofol—Rash—Etoposide—uterine cancer	0.000144	0.00088	CcSEcCtD
Propofol—Dermatitis—Etoposide—uterine cancer	0.000144	0.000879	CcSEcCtD
Propofol—Headache—Etoposide—uterine cancer	0.000143	0.000874	CcSEcCtD
Propofol—Dysgeusia—Doxorubicin—uterine cancer	0.000142	0.000869	CcSEcCtD
Propofol—Syncope—Epirubicin—uterine cancer	0.00014	0.00086	CcSEcCtD
Propofol—Muscle spasms—Doxorubicin—uterine cancer	0.000139	0.000853	CcSEcCtD
Propofol—Loss of consciousness—Epirubicin—uterine cancer	0.000138	0.000843	CcSEcCtD
Propofol—Cough—Epirubicin—uterine cancer	0.000137	0.000837	CcSEcCtD
Propofol—Convulsion—Epirubicin—uterine cancer	0.000136	0.000831	CcSEcCtD
Propofol—Nausea—Etoposide—uterine cancer	0.000135	0.000829	CcSEcCtD
Propofol—Hypertension—Epirubicin—uterine cancer	0.000135	0.000828	CcSEcCtD
Propofol—Chest pain—Epirubicin—uterine cancer	0.000133	0.000816	CcSEcCtD
Propofol—Myalgia—Epirubicin—uterine cancer	0.000133	0.000816	CcSEcCtD
Propofol—Agitation—Doxorubicin—uterine cancer	0.000133	0.000815	CcSEcCtD
Propofol—Anxiety—Epirubicin—uterine cancer	0.000133	0.000813	CcSEcCtD
Propofol—Dry mouth—Epirubicin—uterine cancer	0.00013	0.000798	CcSEcCtD
Propofol—Syncope—Doxorubicin—uterine cancer	0.00013	0.000795	CcSEcCtD
Propofol—Confusional state—Epirubicin—uterine cancer	0.000129	0.000789	CcSEcCtD
Propofol—Oedema—Epirubicin—uterine cancer	0.000128	0.000782	CcSEcCtD
Propofol—Anaphylactic shock—Epirubicin—uterine cancer	0.000128	0.000782	CcSEcCtD
Propofol—Loss of consciousness—Doxorubicin—uterine cancer	0.000127	0.00078	CcSEcCtD
Propofol—Cough—Doxorubicin—uterine cancer	0.000126	0.000774	CcSEcCtD
Propofol—Shock—Epirubicin—uterine cancer	0.000126	0.00077	CcSEcCtD
Propofol—Convulsion—Doxorubicin—uterine cancer	0.000126	0.000769	CcSEcCtD
Propofol—Hypertension—Doxorubicin—uterine cancer	0.000125	0.000766	CcSEcCtD
Propofol—Tachycardia—Epirubicin—uterine cancer	0.000125	0.000764	CcSEcCtD
Propofol—Hyperhidrosis—Epirubicin—uterine cancer	0.000124	0.000756	CcSEcCtD
Propofol—Myalgia—Doxorubicin—uterine cancer	0.000123	0.000755	CcSEcCtD
Propofol—Chest pain—Doxorubicin—uterine cancer	0.000123	0.000755	CcSEcCtD
Propofol—Anxiety—Doxorubicin—uterine cancer	0.000123	0.000753	CcSEcCtD
Propofol—Dry mouth—Doxorubicin—uterine cancer	0.000121	0.000739	CcSEcCtD
Propofol—Hypotension—Epirubicin—uterine cancer	0.000119	0.000731	CcSEcCtD
Propofol—Confusional state—Doxorubicin—uterine cancer	0.000119	0.00073	CcSEcCtD
Propofol—Oedema—Doxorubicin—uterine cancer	0.000118	0.000724	CcSEcCtD
Propofol—Anaphylactic shock—Doxorubicin—uterine cancer	0.000118	0.000724	CcSEcCtD
Propofol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000116	0.000713	CcSEcCtD
Propofol—Shock—Doxorubicin—uterine cancer	0.000116	0.000712	CcSEcCtD
Propofol—Insomnia—Epirubicin—uterine cancer	0.000116	0.000708	CcSEcCtD
Propofol—Tachycardia—Doxorubicin—uterine cancer	0.000115	0.000707	CcSEcCtD
Propofol—Paraesthesia—Epirubicin—uterine cancer	0.000115	0.000703	CcSEcCtD
Propofol—Hyperhidrosis—Doxorubicin—uterine cancer	0.000114	0.0007	CcSEcCtD
Propofol—Dyspnoea—Epirubicin—uterine cancer	0.000114	0.000698	CcSEcCtD
Propofol—Somnolence—Epirubicin—uterine cancer	0.000114	0.000696	CcSEcCtD
Propofol—Hypotension—Doxorubicin—uterine cancer	0.000111	0.000676	CcSEcCtD
Propofol—Fatigue—Epirubicin—uterine cancer	0.00011	0.000675	CcSEcCtD
Propofol—Pain—Epirubicin—uterine cancer	0.000109	0.000669	CcSEcCtD
Propofol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000108	0.00066	CcSEcCtD
Propofol—Insomnia—Doxorubicin—uterine cancer	0.000107	0.000655	CcSEcCtD
Propofol—Paraesthesia—Doxorubicin—uterine cancer	0.000106	0.00065	CcSEcCtD
Propofol—Dyspnoea—Doxorubicin—uterine cancer	0.000105	0.000645	CcSEcCtD
Propofol—Feeling abnormal—Epirubicin—uterine cancer	0.000105	0.000645	CcSEcCtD
Propofol—Somnolence—Doxorubicin—uterine cancer	0.000105	0.000644	CcSEcCtD
Propofol—Fatigue—Doxorubicin—uterine cancer	0.000102	0.000624	CcSEcCtD
Propofol—Urticaria—Epirubicin—uterine cancer	0.000102	0.000622	CcSEcCtD
Propofol—Pain—Doxorubicin—uterine cancer	0.000101	0.000619	CcSEcCtD
Propofol—Abdominal pain—Epirubicin—uterine cancer	0.000101	0.000618	CcSEcCtD
Propofol—Body temperature increased—Epirubicin—uterine cancer	0.000101	0.000618	CcSEcCtD
Propofol—Feeling abnormal—Doxorubicin—uterine cancer	9.75e-05	0.000597	CcSEcCtD
Propofol—Urticaria—Doxorubicin—uterine cancer	9.39e-05	0.000575	CcSEcCtD
Propofol—Abdominal pain—Doxorubicin—uterine cancer	9.35e-05	0.000572	CcSEcCtD
Propofol—Body temperature increased—Doxorubicin—uterine cancer	9.35e-05	0.000572	CcSEcCtD
Propofol—Asthenia—Epirubicin—uterine cancer	9.17e-05	0.000561	CcSEcCtD
Propofol—Pruritus—Epirubicin—uterine cancer	9.04e-05	0.000554	CcSEcCtD
Propofol—Diarrhoea—Epirubicin—uterine cancer	8.74e-05	0.000535	CcSEcCtD
Propofol—Asthenia—Doxorubicin—uterine cancer	8.48e-05	0.000519	CcSEcCtD
Propofol—Dizziness—Epirubicin—uterine cancer	8.45e-05	0.000517	CcSEcCtD
Propofol—Pruritus—Doxorubicin—uterine cancer	8.37e-05	0.000512	CcSEcCtD
Propofol—Vomiting—Epirubicin—uterine cancer	8.13e-05	0.000497	CcSEcCtD
Propofol—Diarrhoea—Doxorubicin—uterine cancer	8.09e-05	0.000495	CcSEcCtD
Propofol—Rash—Epirubicin—uterine cancer	8.06e-05	0.000493	CcSEcCtD
Propofol—Dermatitis—Epirubicin—uterine cancer	8.05e-05	0.000493	CcSEcCtD
Propofol—Headache—Epirubicin—uterine cancer	8.01e-05	0.00049	CcSEcCtD
Propofol—Dizziness—Doxorubicin—uterine cancer	7.82e-05	0.000479	CcSEcCtD
Propofol—Nausea—Epirubicin—uterine cancer	7.59e-05	0.000465	CcSEcCtD
Propofol—Vomiting—Doxorubicin—uterine cancer	7.52e-05	0.00046	CcSEcCtD
Propofol—Rash—Doxorubicin—uterine cancer	7.46e-05	0.000456	CcSEcCtD
Propofol—Dermatitis—Doxorubicin—uterine cancer	7.45e-05	0.000456	CcSEcCtD
Propofol—Headache—Doxorubicin—uterine cancer	7.41e-05	0.000454	CcSEcCtD
Propofol—Nausea—Doxorubicin—uterine cancer	7.02e-05	0.00043	CcSEcCtD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.5e-05	0.000328	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKR1C1—uterine cancer	2.5e-05	0.000327	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKR1C3—uterine cancer	2.49e-05	0.000326	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKR1C3—uterine cancer	2.49e-05	0.000326	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP11A1—uterine cancer	2.46e-05	0.000322	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—STK11—uterine cancer	2.46e-05	0.000322	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CYP19A1—uterine cancer	2.46e-05	0.000322	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—AKT1—uterine cancer	2.41e-05	0.000315	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—AKT1—uterine cancer	2.41e-05	0.000315	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—HRAS—uterine cancer	2.41e-05	0.000315	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.4e-05	0.000314	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—EP300—uterine cancer	2.39e-05	0.000313	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKR1C3—uterine cancer	2.32e-05	0.000304	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—STAR—uterine cancer	2.32e-05	0.000304	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.32e-05	0.000304	CbGpPWpGaD
Propofol—ALB—Metabolism—STAR—uterine cancer	2.31e-05	0.000302	CbGpPWpGaD
Propofol—ALB—Metabolism—AKR1B1—uterine cancer	2.31e-05	0.000302	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.3e-05	0.000301	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.28e-05	0.000299	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—HRAS—uterine cancer	2.26e-05	0.000295	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—HRAS—uterine cancer	2.24e-05	0.000293	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.23e-05	0.000292	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.23e-05	0.000292	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—RRM2—uterine cancer	2.22e-05	0.000291	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—HRAS—uterine cancer	2.2e-05	0.000288	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.17e-05	0.000284	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—DCN—uterine cancer	2.16e-05	0.000283	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—POLD1—uterine cancer	2.15e-05	0.000282	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—POLD1—uterine cancer	2.11e-05	0.000276	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—STAR—uterine cancer	2.07e-05	0.000271	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.07e-05	0.000271	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.05e-05	0.000268	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.05e-05	0.000268	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP11A1—uterine cancer	2.03e-05	0.000266	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.01e-05	0.000264	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—POLD1—uterine cancer	1.99e-05	0.00026	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.97e-05	0.000258	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—STK11—uterine cancer	1.94e-05	0.000254	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CYP19A1—uterine cancer	1.94e-05	0.000254	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—STK11—uterine cancer	1.94e-05	0.000254	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CYP19A1—uterine cancer	1.94e-05	0.000254	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—HRAS—uterine cancer	1.92e-05	0.000252	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.92e-05	0.000252	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.91e-05	0.00025	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—STAR—uterine cancer	1.91e-05	0.00025	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.89e-05	0.000247	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—STAR—uterine cancer	1.89e-05	0.000247	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.87e-05	0.000245	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.86e-05	0.000243	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—MTHFR—uterine cancer	1.85e-05	0.000242	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.84e-05	0.00024	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PTEN—uterine cancer	1.83e-05	0.00024	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.82e-05	0.000239	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—POLD1—uterine cancer	1.82e-05	0.000239	CbGpPWpGaD
Propofol—ALB—Metabolism—POLD1—uterine cancer	1.81e-05	0.000237	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—STK11—uterine cancer	1.81e-05	0.000237	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP19A1—uterine cancer	1.81e-05	0.000237	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—RRM2—uterine cancer	1.8e-05	0.000235	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PIK3CA—uterine cancer	1.77e-05	0.000232	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—RRM2—uterine cancer	1.76e-05	0.00023	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—EP300—uterine cancer	1.75e-05	0.000229	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—DCN—uterine cancer	1.74e-05	0.000228	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.74e-05	0.000228	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.72e-05	0.000226	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.72e-05	0.000226	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—DCN—uterine cancer	1.71e-05	0.000223	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.71e-05	0.000223	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.7e-05	0.000223	CbGpPWpGaD
Propofol—ALB—Metabolism—AKR1C1—uterine cancer	1.7e-05	0.000222	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—RRM2—uterine cancer	1.66e-05	0.000217	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.64e-05	0.000215	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—POLD1—uterine cancer	1.63e-05	0.000213	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.62e-05	0.000212	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.62e-05	0.000211	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—STAR—uterine cancer	1.62e-05	0.000211	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—DCN—uterine cancer	1.61e-05	0.000211	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.61e-05	0.00021	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.6e-05	0.000209	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.55e-05	0.000203	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.52e-05	0.000199	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—RRM2—uterine cancer	1.52e-05	0.000199	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.52e-05	0.000199	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.52e-05	0.000198	CbGpPWpGaD
Propofol—ALB—Metabolism—RRM2—uterine cancer	1.51e-05	0.000198	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—STK11—uterine cancer	1.5e-05	0.000196	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.5e-05	0.000196	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—POLD1—uterine cancer	1.5e-05	0.000196	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—POLD1—uterine cancer	1.48e-05	0.000194	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—DCN—uterine cancer	1.48e-05	0.000193	CbGpPWpGaD
Propofol—ALB—Metabolism—DCN—uterine cancer	1.47e-05	0.000192	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—MTHFR—uterine cancer	1.46e-05	0.000191	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—MTHFR—uterine cancer	1.46e-05	0.000191	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—AKT1—uterine cancer	1.45e-05	0.000189	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.43e-05	0.000188	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.43e-05	0.000187	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.4e-05	0.000183	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.39e-05	0.000182	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.39e-05	0.000182	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000181	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—MTHFR—uterine cancer	1.36e-05	0.000178	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—RRM2—uterine cancer	1.36e-05	0.000178	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—DCN—uterine cancer	1.32e-05	0.000172	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.31e-05	0.000172	CbGpPWpGaD
Propofol—ALB—Metabolism—AKR1C3—uterine cancer	1.31e-05	0.000171	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PIK3CA—uterine cancer	1.29e-05	0.000169	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.29e-05	0.000168	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—POLD1—uterine cancer	1.27e-05	0.000166	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—RRM2—uterine cancer	1.25e-05	0.000163	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.25e-05	0.000163	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—STAR—uterine cancer	1.25e-05	0.000163	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.24e-05	0.000162	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—RRM2—uterine cancer	1.24e-05	0.000162	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—DCN—uterine cancer	1.21e-05	0.000159	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—STK11—uterine cancer	1.21e-05	0.000158	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.21e-05	0.000158	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—DCN—uterine cancer	1.2e-05	0.000157	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.2e-05	0.000157	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.19e-05	0.000155	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.18e-05	0.000155	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—STK11—uterine cancer	1.18e-05	0.000155	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.17e-05	0.000153	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.17e-05	0.000153	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.14e-05	0.000149	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000148	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—MTHFR—uterine cancer	1.13e-05	0.000147	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—STK11—uterine cancer	1.12e-05	0.000146	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.12e-05	0.000146	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.08e-05	0.000141	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.07e-05	0.00014	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—RRM2—uterine cancer	1.06e-05	0.000138	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—uterine cancer	1.06e-05	0.000138	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.05e-05	0.000137	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTEN—uterine cancer	1.03e-05	0.000134	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—DCN—uterine cancer	1.03e-05	0.000134	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—STK11—uterine cancer	1.02e-05	0.000134	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.02e-05	0.000134	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP19A1—uterine cancer	1.02e-05	0.000133	CbGpPWpGaD
Propofol—ALB—Metabolism—STK11—uterine cancer	1.02e-05	0.000133	CbGpPWpGaD
Propofol—ALB—Hemostasis—EP300—uterine cancer	1e-05	0.000131	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.99e-06	0.000131	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—EP300—uterine cancer	9.8e-06	0.000128	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—POLD1—uterine cancer	9.78e-06	0.000128	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP11A1—uterine cancer	9.67e-06	0.000127	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.6e-06	0.000126	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.54e-06	0.000125	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—uterine cancer	9.47e-06	0.000124	CbGpPWpGaD
Propofol—ALB—Hemostasis—NRAS—uterine cancer	9.35e-06	0.000122	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.15e-06	0.00012	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.15e-06	0.00012	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKR1C3—uterine cancer	9.13e-06	0.000119	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP19A1—uterine cancer	9.13e-06	0.000119	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—STK11—uterine cancer	9.13e-06	0.000119	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.1e-06	0.000119	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—MTHFR—uterine cancer	9.08e-06	0.000119	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—MTHFR—uterine cancer	8.89e-06	0.000116	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.57e-06	0.000112	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP19A1—uterine cancer	8.4e-06	0.00011	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—STK11—uterine cancer	8.4e-06	0.00011	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—MTHFR—uterine cancer	8.38e-06	0.00011	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP19A1—uterine cancer	8.32e-06	0.000109	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—STK11—uterine cancer	8.32e-06	0.000109	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.17e-06	0.000107	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—RRM2—uterine cancer	8.16e-06	0.000107	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTEN—uterine cancer	8.12e-06	0.000106	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTEN—uterine cancer	8.12e-06	0.000106	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—uterine cancer	8.05e-06	0.000105	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—DCN—uterine cancer	7.92e-06	0.000104	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.81e-06	0.000102	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—EP300—uterine cancer	7.74e-06	0.000101	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—EP300—uterine cancer	7.74e-06	0.000101	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—MTHFR—uterine cancer	7.68e-06	0.000101	CbGpPWpGaD
Propofol—ALB—Metabolism—MTHFR—uterine cancer	7.64e-06	0.0001	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTEN—uterine cancer	7.57e-06	9.91e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP11A1—uterine cancer	7.46e-06	9.76e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.45e-06	9.75e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—uterine cancer	7.4e-06	9.68e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.39e-06	9.67e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—uterine cancer	7.25e-06	9.48e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—EP300—uterine cancer	7.22e-06	9.45e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—uterine cancer	7.16e-06	9.36e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—STK11—uterine cancer	7.11e-06	9.31e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP19A1—uterine cancer	7.11e-06	9.31e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.05e-06	9.22e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—MTHFR—uterine cancer	6.86e-06	8.98e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—HRAS—uterine cancer	6.84e-06	8.96e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.77e-06	8.86e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.73e-06	8.81e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.68e-06	8.74e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.37e-06	8.33e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—MTHFR—uterine cancer	6.31e-06	8.26e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTEN—uterine cancer	6.26e-06	8.19e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—MTHFR—uterine cancer	6.25e-06	8.19e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.04e-06	7.91e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—uterine cancer	6.04e-06	7.91e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—EP300—uterine cancer	5.97e-06	7.81e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—uterine cancer	5.92e-06	7.75e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—uterine cancer	5.73e-06	7.5e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—uterine cancer	5.73e-06	7.5e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.51e-06	7.21e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—STK11—uterine cancer	5.49e-06	7.18e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.49e-06	7.18e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—MTHFR—uterine cancer	5.34e-06	7e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—uterine cancer	5.34e-06	6.99e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTEN—uterine cancer	5.05e-06	6.61e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTEN—uterine cancer	4.95e-06	6.47e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—EP300—uterine cancer	4.82e-06	6.3e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—EP300—uterine cancer	4.72e-06	6.17e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.71e-06	6.16e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—uterine cancer	4.68e-06	6.12e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—uterine cancer	4.68e-06	6.12e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTEN—uterine cancer	4.66e-06	6.1e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—EP300—uterine cancer	4.45e-06	5.82e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—uterine cancer	4.42e-06	5.78e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—uterine cancer	4.36e-06	5.71e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTEN—uterine cancer	4.28e-06	5.6e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTEN—uterine cancer	4.25e-06	5.56e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—MTHFR—uterine cancer	4.12e-06	5.4e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—EP300—uterine cancer	4.08e-06	5.34e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—EP300—uterine cancer	4.05e-06	5.31e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTEN—uterine cancer	3.82e-06	4.99e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—EP300—uterine cancer	3.64e-06	4.76e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—uterine cancer	3.61e-06	4.72e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.56e-06	4.66e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTEN—uterine cancer	3.51e-06	4.59e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.49e-06	4.57e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTEN—uterine cancer	3.48e-06	4.55e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—EP300—uterine cancer	3.35e-06	4.38e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—EP300—uterine cancer	3.32e-06	4.34e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—uterine cancer	3.29e-06	4.31e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.02e-06	3.95e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—uterine cancer	3e-06	3.92e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTEN—uterine cancer	2.97e-06	3.89e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—uterine cancer	2.91e-06	3.81e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—uterine cancer	2.85e-06	3.73e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—EP300—uterine cancer	2.84e-06	3.71e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.69e-06	3.52e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—uterine cancer	2.69e-06	3.52e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.48e-06	3.24e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—uterine cancer	2.46e-06	3.22e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.45e-06	3.21e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—uterine cancer	2.45e-06	3.21e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTEN—uterine cancer	2.29e-06	3e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—uterine cancer	2.2e-06	2.88e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—EP300—uterine cancer	2.19e-06	2.86e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.1e-06	2.75e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—uterine cancer	2.02e-06	2.65e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—uterine cancer	2.01e-06	2.62e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—uterine cancer	1.71e-06	2.24e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.62e-06	2.12e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—uterine cancer	1.32e-06	1.73e-05	CbGpPWpGaD
